SEPN
Septerna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$38.69
−2.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 19.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.67x
- Price / sales
- 18.26x
- Price / cash flow
- 17.04x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 14.73x
- EV / EBITDA
- -36.63x
- EV / EBIT
- -33.44x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026